D. Tural Et Al. , "Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.," Genitourinary Cancers Symposium , ELECTR NETWORK, 2023
Tural, D. Et Al. 2023. Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.. Genitourinary Cancers Symposium , (ELECTR NETWORK).
Tural, D., Arslan, C., Selcukbiricik, F., Olmez, O. F., Akar, E., Erman, M., ... Urun, Y.(2023). Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma. . Genitourinary Cancers Symposium, ELECTR NETWORK
Tural, Deniz Et Al. "Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.," Genitourinary Cancers Symposium, ELECTR NETWORK, 2023
Tural, Deniz Et Al. "Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.." Genitourinary Cancers Symposium , ELECTR NETWORK, 2023
Tural, D. Et Al. (2023) . "Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.." Genitourinary Cancers Symposium , ELECTR NETWORK.
@conferencepaper{conferencepaper, author={Deniz Tural Et Al. }, title={Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.}, congress name={Genitourinary Cancers Symposium}, city={}, country={ELECTR NETWORK}, year={2023}}